The Basel Breast Consortium is an interdisciplinary organization committed to the development of basic, clinical and translational research projects by supporting interdisciplinary communication and mutual education in Switzerland and neighbouring cities. The presence of outstanding basic science groups, a university hospital and a medical faculty with strong clinical oncology departments, and numerous pharma companies make Basel well-positioned to be the nexus of these collaborative activities.
To discuss, design and conduct scientific projects with the potential to advance knowledge in breast cancer basic biology and therapy to the highest level of targeted therapeutic efficacy while minimizing treatment-related toxicity.
The consortium’s mission is accomplished by regular meetings and networking opportunities among basic researchers, translational research scientists, clinicians – from academia and industry – dedicated to the study of mammary gland development, as well as breast cancer research and treatment in Switzerland and neighbouring cities. Participating clinicians and researchers may have a designated interest in basic or clinical research and originate from the fields of plastic, oncologic and oncoplastic surgery, radiation and medical oncology, gynecology, pathology, radiology and genetics. Participating basic researchers may originate, among others, from a variety of disciplines, including basic cell biology, genetics, immunology, computational biology, endocrinology and fundamental molecular biology.
We organize four joint lunchtime tandem meetings per year. The format is three 15 minutes presentations from basic/translational researchers, clinicians, and industry, while providing 15 additional minutes for discussion and networking.
We are confident that these interactions promote fruitful collaborations in the fields of breast development and breast cancer in Switzerland and neighbouring cities.
With regard to the current Covid-19 situation, please be informed that we are monitoring the BAG recommendations carefully. We will fully comply to preventive measures including social distancing and masks. The health and wellbeing of all participants attending the meeting is our number one priority.
Nov.12-13 2020: BBC Annual Meeting Personalized Breast Cancer Treatments 5
via Zoom only – Information connection will follow
January 27 2020: Prof. Dr. med. Walter Weber receives the Annemarie Karrasch Research Award from the Propatient Foundation. » More information
June 28 2019: SAKK/Pfizer Award 2019 has been awarded to Prof. Dr. med. Walter Weber from University of Basel. » More information
June 27 2019: The team of Dr. Santamaria from the University of Fribourg (CH) published on the influence of TGFBR1 inhibition on tumor and metastasis initiating capacity of breast cancer stem cells. » See article
Feb 15 2018: Walter Weber wins the Claudia von Schilling Award 2017 for his pioneering work in the field of oncoplastic surgery. » See web page
Any help is welcome to support our activities. If you wish to donate please do so by bank transfer on the following account:
Basler Kantonalbank, 4002 Basel
BLZ 770 / SWIFT BKBBCHBB
Konto Nr. 16 477.336.09
IBAN: CH76 0077 0016 0477 3360 9
Lautend auf Universitätsspital Basel, Fonds, Hebelstrasse 36, 4031 Basel
Important notice: FO141054 / YOUR NAME
Please contact xiomara.banholzer at unibas.ch for any inquiry about sponsorship and donations.
Thank you for your support !